TIDMETX

RNS Number : 8457P

e-Therapeutics plc

05 September 2017

E-THERAPEUTICS PLC

("e-therapeutics" or the "Company")

Notification of Half Year Results Date

Oxford, UK - 5 September 2017 - e-therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its half year results for the six months ended 31 July 2017 on Tuesday, 26 September 2017.

-Ends-

For more information, please contact:

 
  e-therapeutics plc                 Tel: +44 (0) 1993 
    Ray Barlow, Chief Executive        883 125 
    Officer                            www.etherapeutics.co.uk 
    Steve Medlicott, Finance 
    Director 
   Numis Securities Limited           Tel: +44 (0) 207 
    Michael Meade/Freddie Barnfield    260 1000 
    (Corporate Finance)                www.numis.com 
    James Black (Corporate 
    Broking) 
   Instinctif Partners                Tel: +44 (0) 207 
    Melanie Toyne Sewell/Alex          457 2020 
    Shaw                               Email: e-therapeutics@instinctif.com

About e-therapeutics plc

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

e-therapeutics is headquartered in Oxford. For more information about the Company please visit www.etherapeutics.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORVELBBDKFZBBB

(END) Dow Jones Newswires

September 05, 2017 04:41 ET (08:41 GMT)

E-therapeutics (LSE:ETX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more E-therapeutics Charts.
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more E-therapeutics Charts.